Global Drug Eluting Balloon Market

Drug Eluting Balloon Comprehensive Study by Type (Coronary, Peripheral, Urology, Others), Application (Hospitals, Others), Technology (FreePac, TransPac, EnduraCoat, Others), Material (Polyurethane, Nylon, Others), End User (Hospitals, Ambulatory Surgical Centers, Others) Players and Region - Global Market Outlook to 2028

Drug Eluting Balloon Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A drug-eluting balloon (DEB) is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through the application of nominal pressure. The active substance of the balloon is highly lipophilic in nature. A drug-eluting balloon homogeneously delivers the drug to the vessel and prevents neointimal hyperplasia. The device has gained popularity as it helps the ineffective treatment of in-stent restenosis as compared to the drug-eluting stent or bare-metal stent. The rise in peripheral and coronary artery diseases among the geriatric population is likely to drive the global drug-eluting balloon market in the forecast period.This growth is primarily driven by Significantly Rising Vascular Disease Incidences .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medtronic Plc (United States), Boston Scientific Corporation (United States), Becton, Dickson and Company (United States), Terumo Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Cook Group Incorporated (United States), Biotronik (Germany), Braun Melsungen AG (Germany), SurModics, Inc. (United States) and C.R. Bard (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In July , 2021 Medtronic plc . the global leader in medical technology, today announced the launch of the Prevail™ drug coated balloon (DCB) Catheter in Europe following CE mark. The newest coronary DCB on the market, the Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).
Oct. 25, 2023 Boston Scientific Corporation announced positive 12-month results from the pivotal AGENT IDE clinical trial of the AGENT™ Drug-Coated Balloon (DCB).1 Primary endpoint findings from this first clinical trial in the U.S. to evaluate the safety and effectiveness of using a DCB to treat coronary in-stent restenosis (ISR) were presented in a late-breaking clinical trial session at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.Drug Eluting Balloon Reasearch in drug eluting ballon catheter space to key players anticipated bolster development and sales.

Influencing Trend:
Growing Demand for DCB Therapy

Market Growth Drivers:
Significantly Rising Vascular Disease Incidences, Growing Prevalence of Peripheral and Coronary Artery Diseases and Rising Geriatric Population across the Globe

Challenges:
Stringent Regulations For Approval

Restraints:
High Cost of Procedures and Products

Opportunities:
Rising Use of Drug-eluting Balloons Over Drug-Eluting Stents

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Drug Eluting Balloon Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Drug Eluting Balloon Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Drug Eluting Balloon players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Drug Eluting Balloon Study Sheds Light on
— The Drug Eluting Balloon Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Drug Eluting Balloon industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Drug Eluting Balloon industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Coronary
  • Peripheral
  • Urology
  • Others
By Application
  • Hospitals
  • Others
By Technology
  • FreePac
  • TransPac
  • EnduraCoat
  • Others

By Material
  • Polyurethane
  • Nylon
  • Others

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Significantly Rising Vascular Disease Incidences
      • 3.2.2. Growing Prevalence of Peripheral and Coronary Artery Diseases
      • 3.2.3. Rising Geriatric Population across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations For Approval
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for DCB Therapy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Eluting Balloon, by Type, Application, Technology, Material, End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Drug Eluting Balloon (Value)
      • 5.2.1. Global Drug Eluting Balloon by: Type (Value)
        • 5.2.1.1. Coronary
        • 5.2.1.2. Peripheral
        • 5.2.1.3. Urology
        • 5.2.1.4. Others
      • 5.2.2. Global Drug Eluting Balloon by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Others
      • 5.2.3. Global Drug Eluting Balloon by: Technology (Value)
        • 5.2.3.1. FreePac
        • 5.2.3.2. TransPac
        • 5.2.3.3. EnduraCoat
        • 5.2.3.4. Others
      • 5.2.4. Global Drug Eluting Balloon by: Material (Value)
        • 5.2.4.1. Polyurethane
        • 5.2.4.2. Nylon
        • 5.2.4.3. Others
      • 5.2.5. Global Drug Eluting Balloon by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Ambulatory Surgical Centers
        • 5.2.5.3. Others
      • 5.2.6. Global Drug Eluting Balloon Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Drug Eluting Balloon (Volume)
      • 5.3.1. Global Drug Eluting Balloon by: Type (Volume)
        • 5.3.1.1. Coronary
        • 5.3.1.2. Peripheral
        • 5.3.1.3. Urology
        • 5.3.1.4. Others
      • 5.3.2. Global Drug Eluting Balloon by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Others
      • 5.3.3. Global Drug Eluting Balloon by: Technology (Volume)
        • 5.3.3.1. FreePac
        • 5.3.3.2. TransPac
        • 5.3.3.3. EnduraCoat
        • 5.3.3.4. Others
      • 5.3.4. Global Drug Eluting Balloon by: Material (Volume)
        • 5.3.4.1. Polyurethane
        • 5.3.4.2. Nylon
        • 5.3.4.3. Others
      • 5.3.5. Global Drug Eluting Balloon by: End User (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Ambulatory Surgical Centers
        • 5.3.5.3. Others
      • 5.3.6. Global Drug Eluting Balloon Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Drug Eluting Balloon (Price)
      • 5.4.1. Global Drug Eluting Balloon by: Type (Price)
  • 6. Drug Eluting Balloon: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic Plc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton, Dickson and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Terumo Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cook Group Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biotronik (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Braun Melsungen AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SurModics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. C.R. Bard (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Drug Eluting Balloon Sale, by Type, Application, Technology, Material, End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Drug Eluting Balloon (Value)
      • 7.2.1. Global Drug Eluting Balloon by: Type (Value)
        • 7.2.1.1. Coronary
        • 7.2.1.2. Peripheral
        • 7.2.1.3. Urology
        • 7.2.1.4. Others
      • 7.2.2. Global Drug Eluting Balloon by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Others
      • 7.2.3. Global Drug Eluting Balloon by: Technology (Value)
        • 7.2.3.1. FreePac
        • 7.2.3.2. TransPac
        • 7.2.3.3. EnduraCoat
        • 7.2.3.4. Others
      • 7.2.4. Global Drug Eluting Balloon by: Material (Value)
        • 7.2.4.1. Polyurethane
        • 7.2.4.2. Nylon
        • 7.2.4.3. Others
      • 7.2.5. Global Drug Eluting Balloon by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Ambulatory Surgical Centers
        • 7.2.5.3. Others
      • 7.2.6. Global Drug Eluting Balloon Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Drug Eluting Balloon (Volume)
      • 7.3.1. Global Drug Eluting Balloon by: Type (Volume)
        • 7.3.1.1. Coronary
        • 7.3.1.2. Peripheral
        • 7.3.1.3. Urology
        • 7.3.1.4. Others
      • 7.3.2. Global Drug Eluting Balloon by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Others
      • 7.3.3. Global Drug Eluting Balloon by: Technology (Volume)
        • 7.3.3.1. FreePac
        • 7.3.3.2. TransPac
        • 7.3.3.3. EnduraCoat
        • 7.3.3.4. Others
      • 7.3.4. Global Drug Eluting Balloon by: Material (Volume)
        • 7.3.4.1. Polyurethane
        • 7.3.4.2. Nylon
        • 7.3.4.3. Others
      • 7.3.5. Global Drug Eluting Balloon by: End User (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Ambulatory Surgical Centers
        • 7.3.5.3. Others
      • 7.3.6. Global Drug Eluting Balloon Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Drug Eluting Balloon (Price)
      • 7.4.1. Global Drug Eluting Balloon by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Eluting Balloon: by Type(USD Million)
  • Table 2. Drug Eluting Balloon Coronary , by Region USD Million (2017-2022)
  • Table 3. Drug Eluting Balloon Peripheral , by Region USD Million (2017-2022)
  • Table 4. Drug Eluting Balloon Urology , by Region USD Million (2017-2022)
  • Table 5. Drug Eluting Balloon Others , by Region USD Million (2017-2022)
  • Table 6. Drug Eluting Balloon: by Application(USD Million)
  • Table 7. Drug Eluting Balloon Hospitals , by Region USD Million (2017-2022)
  • Table 8. Drug Eluting Balloon Others , by Region USD Million (2017-2022)
  • Table 9. Drug Eluting Balloon: by Technology(USD Million)
  • Table 10. Drug Eluting Balloon FreePac , by Region USD Million (2017-2022)
  • Table 11. Drug Eluting Balloon TransPac , by Region USD Million (2017-2022)
  • Table 12. Drug Eluting Balloon EnduraCoat , by Region USD Million (2017-2022)
  • Table 13. Drug Eluting Balloon Others , by Region USD Million (2017-2022)
  • Table 14. Drug Eluting Balloon: by Material(USD Million)
  • Table 15. Drug Eluting Balloon Polyurethane , by Region USD Million (2017-2022)
  • Table 16. Drug Eluting Balloon Nylon , by Region USD Million (2017-2022)
  • Table 17. Drug Eluting Balloon Others , by Region USD Million (2017-2022)
  • Table 18. Drug Eluting Balloon: by End User(USD Million)
  • Table 19. Drug Eluting Balloon Hospitals , by Region USD Million (2017-2022)
  • Table 20. Drug Eluting Balloon Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 21. Drug Eluting Balloon Others , by Region USD Million (2017-2022)
  • Table 22. South America Drug Eluting Balloon, by Country USD Million (2017-2022)
  • Table 23. South America Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 24. South America Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 25. South America Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 26. South America Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 27. South America Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 28. Brazil Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 29. Brazil Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 30. Brazil Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 31. Brazil Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 32. Brazil Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 33. Argentina Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 34. Argentina Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 35. Argentina Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 36. Argentina Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 37. Argentina Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 38. Rest of South America Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 39. Rest of South America Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 40. Rest of South America Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 41. Rest of South America Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 42. Rest of South America Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 43. Asia Pacific Drug Eluting Balloon, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 45. Asia Pacific Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 46. Asia Pacific Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 47. Asia Pacific Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 48. Asia Pacific Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 49. China Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 50. China Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 51. China Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 52. China Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 53. China Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 54. Japan Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 55. Japan Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 56. Japan Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 57. Japan Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 58. Japan Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 59. India Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 60. India Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 61. India Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 62. India Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 63. India Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 64. South Korea Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 65. South Korea Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 66. South Korea Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 67. South Korea Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 68. South Korea Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 69. Taiwan Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 70. Taiwan Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 71. Taiwan Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 72. Taiwan Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 73. Taiwan Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 74. Australia Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 75. Australia Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 76. Australia Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 77. Australia Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 78. Australia Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 84. Europe Drug Eluting Balloon, by Country USD Million (2017-2022)
  • Table 85. Europe Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 86. Europe Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 87. Europe Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 88. Europe Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 89. Europe Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 90. Germany Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 91. Germany Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 92. Germany Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 93. Germany Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 94. Germany Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 95. France Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 96. France Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 97. France Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 98. France Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 99. France Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 100. Italy Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 101. Italy Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 102. Italy Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 103. Italy Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 104. Italy Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 105. United Kingdom Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 106. United Kingdom Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 107. United Kingdom Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 108. United Kingdom Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 109. United Kingdom Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 110. Netherlands Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 111. Netherlands Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 112. Netherlands Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 113. Netherlands Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 114. Netherlands Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 115. Rest of Europe Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 116. Rest of Europe Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 117. Rest of Europe Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 118. Rest of Europe Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 119. Rest of Europe Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 120. MEA Drug Eluting Balloon, by Country USD Million (2017-2022)
  • Table 121. MEA Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 122. MEA Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 123. MEA Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 124. MEA Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 125. MEA Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 126. Middle East Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 127. Middle East Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 128. Middle East Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 129. Middle East Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 130. Middle East Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 131. Africa Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 132. Africa Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 133. Africa Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 134. Africa Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 135. Africa Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 136. North America Drug Eluting Balloon, by Country USD Million (2017-2022)
  • Table 137. North America Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 138. North America Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 139. North America Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 140. North America Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 141. North America Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 142. United States Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 143. United States Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 144. United States Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 145. United States Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 146. United States Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 147. Canada Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 148. Canada Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 149. Canada Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 150. Canada Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 151. Canada Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 152. Mexico Drug Eluting Balloon, by Type USD Million (2017-2022)
  • Table 153. Mexico Drug Eluting Balloon, by Application USD Million (2017-2022)
  • Table 154. Mexico Drug Eluting Balloon, by Technology USD Million (2017-2022)
  • Table 155. Mexico Drug Eluting Balloon, by Material USD Million (2017-2022)
  • Table 156. Mexico Drug Eluting Balloon, by End User USD Million (2017-2022)
  • Table 157. Drug Eluting Balloon Sales: by Type(K Units)
  • Table 158. Drug Eluting Balloon Sales Coronary , by Region K Units (2017-2022)
  • Table 159. Drug Eluting Balloon Sales Peripheral , by Region K Units (2017-2022)
  • Table 160. Drug Eluting Balloon Sales Urology , by Region K Units (2017-2022)
  • Table 161. Drug Eluting Balloon Sales Others , by Region K Units (2017-2022)
  • Table 162. Drug Eluting Balloon Sales: by Application(K Units)
  • Table 163. Drug Eluting Balloon Sales Hospitals , by Region K Units (2017-2022)
  • Table 164. Drug Eluting Balloon Sales Others , by Region K Units (2017-2022)
  • Table 165. Drug Eluting Balloon Sales: by Technology(K Units)
  • Table 166. Drug Eluting Balloon Sales FreePac , by Region K Units (2017-2022)
  • Table 167. Drug Eluting Balloon Sales TransPac , by Region K Units (2017-2022)
  • Table 168. Drug Eluting Balloon Sales EnduraCoat , by Region K Units (2017-2022)
  • Table 169. Drug Eluting Balloon Sales Others , by Region K Units (2017-2022)
  • Table 170. Drug Eluting Balloon Sales: by Material(K Units)
  • Table 171. Drug Eluting Balloon Sales Polyurethane , by Region K Units (2017-2022)
  • Table 172. Drug Eluting Balloon Sales Nylon , by Region K Units (2017-2022)
  • Table 173. Drug Eluting Balloon Sales Others , by Region K Units (2017-2022)
  • Table 174. Drug Eluting Balloon Sales: by End User(K Units)
  • Table 175. Drug Eluting Balloon Sales Hospitals , by Region K Units (2017-2022)
  • Table 176. Drug Eluting Balloon Sales Ambulatory Surgical Centers , by Region K Units (2017-2022)
  • Table 177. Drug Eluting Balloon Sales Others , by Region K Units (2017-2022)
  • Table 178. South America Drug Eluting Balloon Sales, by Country K Units (2017-2022)
  • Table 179. South America Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 180. South America Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 181. South America Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 182. South America Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 183. South America Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 184. Brazil Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 185. Brazil Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 186. Brazil Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 187. Brazil Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 188. Brazil Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 189. Argentina Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 190. Argentina Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 191. Argentina Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 192. Argentina Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 193. Argentina Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 194. Rest of South America Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 195. Rest of South America Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 196. Rest of South America Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 197. Rest of South America Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 198. Rest of South America Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 199. Asia Pacific Drug Eluting Balloon Sales, by Country K Units (2017-2022)
  • Table 200. Asia Pacific Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 201. Asia Pacific Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 202. Asia Pacific Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 203. Asia Pacific Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 204. Asia Pacific Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 205. China Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 206. China Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 207. China Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 208. China Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 209. China Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 210. Japan Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 211. Japan Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 212. Japan Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 213. Japan Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 214. Japan Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 215. India Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 216. India Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 217. India Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 218. India Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 219. India Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 220. South Korea Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 221. South Korea Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 222. South Korea Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 223. South Korea Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 224. South Korea Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 225. Taiwan Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 226. Taiwan Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 227. Taiwan Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 228. Taiwan Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 229. Taiwan Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 230. Australia Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 231. Australia Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 232. Australia Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 233. Australia Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 234. Australia Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 235. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 236. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 237. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 238. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 239. Rest of Asia-Pacific Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 240. Europe Drug Eluting Balloon Sales, by Country K Units (2017-2022)
  • Table 241. Europe Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 242. Europe Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 243. Europe Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 244. Europe Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 245. Europe Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 246. Germany Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 247. Germany Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 248. Germany Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 249. Germany Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 250. Germany Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 251. France Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 252. France Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 253. France Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 254. France Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 255. France Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 256. Italy Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 257. Italy Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 258. Italy Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 259. Italy Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 260. Italy Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 261. United Kingdom Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 262. United Kingdom Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 263. United Kingdom Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 264. United Kingdom Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 265. United Kingdom Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 266. Netherlands Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 267. Netherlands Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 268. Netherlands Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 269. Netherlands Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 270. Netherlands Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 271. Rest of Europe Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 272. Rest of Europe Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 273. Rest of Europe Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 274. Rest of Europe Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 275. Rest of Europe Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 276. MEA Drug Eluting Balloon Sales, by Country K Units (2017-2022)
  • Table 277. MEA Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 278. MEA Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 279. MEA Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 280. MEA Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 281. MEA Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 282. Middle East Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 283. Middle East Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 284. Middle East Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 285. Middle East Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 286. Middle East Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 287. Africa Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 288. Africa Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 289. Africa Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 290. Africa Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 291. Africa Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 292. North America Drug Eluting Balloon Sales, by Country K Units (2017-2022)
  • Table 293. North America Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 294. North America Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 295. North America Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 296. North America Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 297. North America Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 298. United States Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 299. United States Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 300. United States Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 301. United States Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 302. United States Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 303. Canada Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 304. Canada Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 305. Canada Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 306. Canada Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 307. Canada Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 308. Mexico Drug Eluting Balloon Sales, by Type K Units (2017-2022)
  • Table 309. Mexico Drug Eluting Balloon Sales, by Application K Units (2017-2022)
  • Table 310. Mexico Drug Eluting Balloon Sales, by Technology K Units (2017-2022)
  • Table 311. Mexico Drug Eluting Balloon Sales, by Material K Units (2017-2022)
  • Table 312. Mexico Drug Eluting Balloon Sales, by End User K Units (2017-2022)
  • Table 313. Drug Eluting Balloon: by Type(USD/Units)
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Drug Eluting Balloon: by Type(USD Million)
  • Table 325. Drug Eluting Balloon Coronary , by Region USD Million (2023-2028)
  • Table 326. Drug Eluting Balloon Peripheral , by Region USD Million (2023-2028)
  • Table 327. Drug Eluting Balloon Urology , by Region USD Million (2023-2028)
  • Table 328. Drug Eluting Balloon Others , by Region USD Million (2023-2028)
  • Table 329. Drug Eluting Balloon: by Application(USD Million)
  • Table 330. Drug Eluting Balloon Hospitals , by Region USD Million (2023-2028)
  • Table 331. Drug Eluting Balloon Others , by Region USD Million (2023-2028)
  • Table 332. Drug Eluting Balloon: by Technology(USD Million)
  • Table 333. Drug Eluting Balloon FreePac , by Region USD Million (2023-2028)
  • Table 334. Drug Eluting Balloon TransPac , by Region USD Million (2023-2028)
  • Table 335. Drug Eluting Balloon EnduraCoat , by Region USD Million (2023-2028)
  • Table 336. Drug Eluting Balloon Others , by Region USD Million (2023-2028)
  • Table 337. Drug Eluting Balloon: by Material(USD Million)
  • Table 338. Drug Eluting Balloon Polyurethane , by Region USD Million (2023-2028)
  • Table 339. Drug Eluting Balloon Nylon , by Region USD Million (2023-2028)
  • Table 340. Drug Eluting Balloon Others , by Region USD Million (2023-2028)
  • Table 341. Drug Eluting Balloon: by End User(USD Million)
  • Table 342. Drug Eluting Balloon Hospitals , by Region USD Million (2023-2028)
  • Table 343. Drug Eluting Balloon Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 344. Drug Eluting Balloon Others , by Region USD Million (2023-2028)
  • Table 345. South America Drug Eluting Balloon, by Country USD Million (2023-2028)
  • Table 346. South America Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 347. South America Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 348. South America Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 349. South America Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 350. South America Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 351. Brazil Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 352. Brazil Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 353. Brazil Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 354. Brazil Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 355. Brazil Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 356. Argentina Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 357. Argentina Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 358. Argentina Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 359. Argentina Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 360. Argentina Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 361. Rest of South America Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 362. Rest of South America Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 363. Rest of South America Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 364. Rest of South America Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 365. Rest of South America Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 366. Asia Pacific Drug Eluting Balloon, by Country USD Million (2023-2028)
  • Table 367. Asia Pacific Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 368. Asia Pacific Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 369. Asia Pacific Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 370. Asia Pacific Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 371. Asia Pacific Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 372. China Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 373. China Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 374. China Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 375. China Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 376. China Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 377. Japan Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 378. Japan Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 379. Japan Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 380. Japan Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 381. Japan Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 382. India Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 383. India Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 384. India Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 385. India Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 386. India Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 387. South Korea Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 388. South Korea Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 389. South Korea Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 390. South Korea Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 391. South Korea Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 392. Taiwan Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 393. Taiwan Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 394. Taiwan Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 395. Taiwan Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 396. Taiwan Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 397. Australia Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 398. Australia Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 399. Australia Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 400. Australia Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 401. Australia Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 402. Rest of Asia-Pacific Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 403. Rest of Asia-Pacific Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 404. Rest of Asia-Pacific Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 405. Rest of Asia-Pacific Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 406. Rest of Asia-Pacific Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 407. Europe Drug Eluting Balloon, by Country USD Million (2023-2028)
  • Table 408. Europe Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 409. Europe Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 410. Europe Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 411. Europe Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 412. Europe Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 413. Germany Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 414. Germany Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 415. Germany Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 416. Germany Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 417. Germany Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 418. France Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 419. France Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 420. France Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 421. France Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 422. France Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 423. Italy Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 424. Italy Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 425. Italy Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 426. Italy Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 427. Italy Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 428. United Kingdom Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 429. United Kingdom Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 430. United Kingdom Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 431. United Kingdom Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 432. United Kingdom Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 433. Netherlands Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 434. Netherlands Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 435. Netherlands Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 436. Netherlands Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 437. Netherlands Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 438. Rest of Europe Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 439. Rest of Europe Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 440. Rest of Europe Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 441. Rest of Europe Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 442. Rest of Europe Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 443. MEA Drug Eluting Balloon, by Country USD Million (2023-2028)
  • Table 444. MEA Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 445. MEA Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 446. MEA Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 447. MEA Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 448. MEA Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 449. Middle East Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 450. Middle East Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 451. Middle East Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 452. Middle East Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 453. Middle East Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 454. Africa Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 455. Africa Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 456. Africa Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 457. Africa Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 458. Africa Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 459. North America Drug Eluting Balloon, by Country USD Million (2023-2028)
  • Table 460. North America Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 461. North America Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 462. North America Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 463. North America Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 464. North America Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 465. United States Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 466. United States Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 467. United States Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 468. United States Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 469. United States Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 470. Canada Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 471. Canada Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 472. Canada Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 473. Canada Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 474. Canada Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 475. Mexico Drug Eluting Balloon, by Type USD Million (2023-2028)
  • Table 476. Mexico Drug Eluting Balloon, by Application USD Million (2023-2028)
  • Table 477. Mexico Drug Eluting Balloon, by Technology USD Million (2023-2028)
  • Table 478. Mexico Drug Eluting Balloon, by Material USD Million (2023-2028)
  • Table 479. Mexico Drug Eluting Balloon, by End User USD Million (2023-2028)
  • Table 480. Drug Eluting Balloon Sales: by Type(K Units)
  • Table 481. Drug Eluting Balloon Sales Coronary , by Region K Units (2023-2028)
  • Table 482. Drug Eluting Balloon Sales Peripheral , by Region K Units (2023-2028)
  • Table 483. Drug Eluting Balloon Sales Urology , by Region K Units (2023-2028)
  • Table 484. Drug Eluting Balloon Sales Others , by Region K Units (2023-2028)
  • Table 485. Drug Eluting Balloon Sales: by Application(K Units)
  • Table 486. Drug Eluting Balloon Sales Hospitals , by Region K Units (2023-2028)
  • Table 487. Drug Eluting Balloon Sales Others , by Region K Units (2023-2028)
  • Table 488. Drug Eluting Balloon Sales: by Technology(K Units)
  • Table 489. Drug Eluting Balloon Sales FreePac , by Region K Units (2023-2028)
  • Table 490. Drug Eluting Balloon Sales TransPac , by Region K Units (2023-2028)
  • Table 491. Drug Eluting Balloon Sales EnduraCoat , by Region K Units (2023-2028)
  • Table 492. Drug Eluting Balloon Sales Others , by Region K Units (2023-2028)
  • Table 493. Drug Eluting Balloon Sales: by Material(K Units)
  • Table 494. Drug Eluting Balloon Sales Polyurethane , by Region K Units (2023-2028)
  • Table 495. Drug Eluting Balloon Sales Nylon , by Region K Units (2023-2028)
  • Table 496. Drug Eluting Balloon Sales Others , by Region K Units (2023-2028)
  • Table 497. Drug Eluting Balloon Sales: by End User(K Units)
  • Table 498. Drug Eluting Balloon Sales Hospitals , by Region K Units (2023-2028)
  • Table 499. Drug Eluting Balloon Sales Ambulatory Surgical Centers , by Region K Units (2023-2028)
  • Table 500. Drug Eluting Balloon Sales Others , by Region K Units (2023-2028)
  • Table 501. South America Drug Eluting Balloon Sales, by Country K Units (2023-2028)
  • Table 502. South America Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 503. South America Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 504. South America Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 505. South America Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 506. South America Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 507. Brazil Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 508. Brazil Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 509. Brazil Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 510. Brazil Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 511. Brazil Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 512. Argentina Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 513. Argentina Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 514. Argentina Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 515. Argentina Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 516. Argentina Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 517. Rest of South America Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 518. Rest of South America Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 519. Rest of South America Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 520. Rest of South America Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 521. Rest of South America Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 522. Asia Pacific Drug Eluting Balloon Sales, by Country K Units (2023-2028)
  • Table 523. Asia Pacific Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 524. Asia Pacific Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 525. Asia Pacific Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 526. Asia Pacific Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 527. Asia Pacific Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 528. China Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 529. China Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 530. China Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 531. China Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 532. China Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 533. Japan Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 534. Japan Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 535. Japan Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 536. Japan Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 537. Japan Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 538. India Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 539. India Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 540. India Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 541. India Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 542. India Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 543. South Korea Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 544. South Korea Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 545. South Korea Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 546. South Korea Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 547. South Korea Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 548. Taiwan Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 549. Taiwan Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 550. Taiwan Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 551. Taiwan Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 552. Taiwan Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 553. Australia Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 554. Australia Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 555. Australia Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 556. Australia Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 557. Australia Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 558. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 559. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 560. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 561. Rest of Asia-Pacific Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 562. Rest of Asia-Pacific Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 563. Europe Drug Eluting Balloon Sales, by Country K Units (2023-2028)
  • Table 564. Europe Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 565. Europe Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 566. Europe Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 567. Europe Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 568. Europe Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 569. Germany Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 570. Germany Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 571. Germany Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 572. Germany Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 573. Germany Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 574. France Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 575. France Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 576. France Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 577. France Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 578. France Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 579. Italy Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 580. Italy Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 581. Italy Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 582. Italy Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 583. Italy Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 584. United Kingdom Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 585. United Kingdom Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 586. United Kingdom Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 587. United Kingdom Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 588. United Kingdom Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 589. Netherlands Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 590. Netherlands Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 591. Netherlands Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 592. Netherlands Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 593. Netherlands Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 594. Rest of Europe Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 595. Rest of Europe Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 596. Rest of Europe Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 597. Rest of Europe Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 598. Rest of Europe Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 599. MEA Drug Eluting Balloon Sales, by Country K Units (2023-2028)
  • Table 600. MEA Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 601. MEA Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 602. MEA Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 603. MEA Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 604. MEA Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 605. Middle East Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 606. Middle East Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 607. Middle East Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 608. Middle East Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 609. Middle East Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 610. Africa Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 611. Africa Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 612. Africa Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 613. Africa Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 614. Africa Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 615. North America Drug Eluting Balloon Sales, by Country K Units (2023-2028)
  • Table 616. North America Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 617. North America Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 618. North America Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 619. North America Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 620. North America Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 621. United States Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 622. United States Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 623. United States Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 624. United States Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 625. United States Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 626. Canada Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 627. Canada Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 628. Canada Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 629. Canada Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 630. Canada Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 631. Mexico Drug Eluting Balloon Sales, by Type K Units (2023-2028)
  • Table 632. Mexico Drug Eluting Balloon Sales, by Application K Units (2023-2028)
  • Table 633. Mexico Drug Eluting Balloon Sales, by Technology K Units (2023-2028)
  • Table 634. Mexico Drug Eluting Balloon Sales, by Material K Units (2023-2028)
  • Table 635. Mexico Drug Eluting Balloon Sales, by End User K Units (2023-2028)
  • Table 636. Drug Eluting Balloon: by Type(USD/Units)
  • Table 637. Research Programs/Design for This Report
  • Table 638. Key Data Information from Secondary Sources
  • Table 639. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Eluting Balloon: by Type USD Million (2017-2022)
  • Figure 5. Global Drug Eluting Balloon: by Application USD Million (2017-2022)
  • Figure 6. Global Drug Eluting Balloon: by Technology USD Million (2017-2022)
  • Figure 7. Global Drug Eluting Balloon: by Material USD Million (2017-2022)
  • Figure 8. Global Drug Eluting Balloon: by End User USD Million (2017-2022)
  • Figure 9. South America Drug Eluting Balloon Share (%), by Country
  • Figure 10. Asia Pacific Drug Eluting Balloon Share (%), by Country
  • Figure 11. Europe Drug Eluting Balloon Share (%), by Country
  • Figure 12. MEA Drug Eluting Balloon Share (%), by Country
  • Figure 13. North America Drug Eluting Balloon Share (%), by Country
  • Figure 14. Global Drug Eluting Balloon: by Type K Units (2017-2022)
  • Figure 15. Global Drug Eluting Balloon: by Application K Units (2017-2022)
  • Figure 16. Global Drug Eluting Balloon: by Technology K Units (2017-2022)
  • Figure 17. Global Drug Eluting Balloon: by Material K Units (2017-2022)
  • Figure 18. Global Drug Eluting Balloon: by End User K Units (2017-2022)
  • Figure 19. South America Drug Eluting Balloon Share (%), by Country
  • Figure 20. Asia Pacific Drug Eluting Balloon Share (%), by Country
  • Figure 21. Europe Drug Eluting Balloon Share (%), by Country
  • Figure 22. MEA Drug Eluting Balloon Share (%), by Country
  • Figure 23. North America Drug Eluting Balloon Share (%), by Country
  • Figure 24. Global Drug Eluting Balloon: by Type USD/Units (2017-2022)
  • Figure 25. Global Drug Eluting Balloon share by Players 2022 (%)
  • Figure 26. Global Drug Eluting Balloon share by Players (Top 3) 2022(%)
  • Figure 27. Global Drug Eluting Balloon share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Medtronic Plc (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic Plc (United States) Revenue: by Geography 2022
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 33. Becton, Dickson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 34. Becton, Dickson and Company (United States) Revenue: by Geography 2022
  • Figure 35. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Terumo Corporation (Japan) Revenue: by Geography 2022
  • Figure 37. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 38. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 39. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 40. Cook Group Incorporated (United States) Revenue: by Geography 2022
  • Figure 41. Biotronik (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Biotronik (Germany) Revenue: by Geography 2022
  • Figure 43. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 45. SurModics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. SurModics, Inc. (United States) Revenue: by Geography 2022
  • Figure 47. C.R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 48. C.R. Bard (United States) Revenue: by Geography 2022
  • Figure 49. Global Drug Eluting Balloon: by Type USD Million (2023-2028)
  • Figure 50. Global Drug Eluting Balloon: by Application USD Million (2023-2028)
  • Figure 51. Global Drug Eluting Balloon: by Technology USD Million (2023-2028)
  • Figure 52. Global Drug Eluting Balloon: by Material USD Million (2023-2028)
  • Figure 53. Global Drug Eluting Balloon: by End User USD Million (2023-2028)
  • Figure 54. South America Drug Eluting Balloon Share (%), by Country
  • Figure 55. Asia Pacific Drug Eluting Balloon Share (%), by Country
  • Figure 56. Europe Drug Eluting Balloon Share (%), by Country
  • Figure 57. MEA Drug Eluting Balloon Share (%), by Country
  • Figure 58. North America Drug Eluting Balloon Share (%), by Country
  • Figure 59. Global Drug Eluting Balloon: by Type K Units (2023-2028)
  • Figure 60. Global Drug Eluting Balloon: by Application K Units (2023-2028)
  • Figure 61. Global Drug Eluting Balloon: by Technology K Units (2023-2028)
  • Figure 62. Global Drug Eluting Balloon: by Material K Units (2023-2028)
  • Figure 63. Global Drug Eluting Balloon: by End User K Units (2023-2028)
  • Figure 64. South America Drug Eluting Balloon Share (%), by Country
  • Figure 65. Asia Pacific Drug Eluting Balloon Share (%), by Country
  • Figure 66. Europe Drug Eluting Balloon Share (%), by Country
  • Figure 67. MEA Drug Eluting Balloon Share (%), by Country
  • Figure 68. North America Drug Eluting Balloon Share (%), by Country
  • Figure 69. Global Drug Eluting Balloon: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Medtronic Plc (United States)
  • Boston Scientific Corporation (United States)
  • Becton, Dickson and Company (United States)
  • Terumo Corporation (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • Cook Group Incorporated (United States)
  • Biotronik (Germany)
  • Braun Melsungen AG (Germany)
  • SurModics, Inc. (United States)
  • C.R. Bard (United States)
Additional players considered in the study are as follows:
B. Braun (Germany) , Eurocor GmbH (Germany) , M.A. MedAlliance SA (Switzerland) , Cardionovum GmbH (Germany)
Select User Access Type

Key Highlights of Report


Dec 2023 226 Pages 93 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Eluting Balloon Market Quantitative research analysis
Global Drug Eluting Balloon Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Drug Eluting Balloon Market are Medtronic Plc (United States), Boston Scientific Corporation (United States), Becton, Dickson and Company (United States), Terumo Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Cook Group Incorporated (United States), Biotronik (Germany), Braun Melsungen AG (Germany), SurModics, Inc. (United States) and C.R. Bard (United States) etc.
Hospitals segment in Global market to hold robust market share owing to "Significantly Rising Vascular Disease Incidences ".
AMA Research predicts that European and United States Players will contribute to the maximum growth of Global Drug Eluting Balloon market throughout the forecasted period.

Know More About Global Drug Eluting Balloon Market Report?

Have a Query? Click Here

Other Related Reports

Antidiarrheal Drugs Comprehensive Study by Type (OTC Drugs, Prescription Drugs, Others), Application (Adults, Children), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, Others), Dru...
$ 3450
Mental Illness Drugs Comprehensive Study by Type (Antipsychotics, Antidepressants, Antianxiety (anxiolytics), Anti-seizure medications), Application (Hospital, Clinic, Drugstore), Distribution Channe...
$ 3750
Fish Vaccine Comprehensive Study by Type (Live, Inactivated, Subunit, DNA, Others), Application (Body in learning how to protect it from viruses), Administration (Oral, Immersion, Injected), Fish (Sa...
$ 3500
Dermatophytosis Drugs Comprehensive Study by Application (Superficial Antifungal Infections, Systemic Antifungal Infections), Route of Administration (Oral, Topical, Parenteral), Form (Powder, Ointme...
$ 3350
Pharmaceutical and Medicinal Herbal Extracts Comprehensive Study by Type (Capsule, Tablet, Powder, Others), Application (Treatment, Massage, Medicines), End-Use (Traditional Chinese Medicine, Western...
$ 3350
Clopidogrel Bisulfate Comprehensive Study by Application (Heart Attacks, Strokes, Peripheral Arterial Diseases), End-users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Ret...
$ 3350